Radware Reports Fourth Quarter and Full Year 2024 Financial Results
Fourth Quarter 2024 Financial Results and Highlights Revenue of $73 million, an…
EYLEA HD (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting
EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior…
Three-Year Results for EYLEA HD (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals
At three years of EYLEA HD treatment, the vast majority of patients…
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program
February 08, 2025 14:30 ET | Source: 4D Molecular Therapeutics, Inc. 3E10…
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 06, 2025 16:35 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update
February 06, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Bilibili Inc. to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on Thursday, February 20, 2025
Earnings Call Scheduled for 7:00 a.m. ET on February 20, 2025 February…
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
February 05, 2025 18:15 ET | Source: BriaCell Therapeutics Corp. PHILADELPHIA, Pa.…
Euroclear continues to deliver strong results in 2024
BRUSSELS, Feb. 5, 2025 /PRNewswire/ -- Results for the year ending 31…
Kia Announces January 2025 Global Sales Results
January 2025 global sales of 239,571 units, down 2.4% Y/yOutside of Korea,…